4.3 Article

Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw

Toshiyuki Yoneda et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2017)

Article Medicine, General & Internal

Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw

Akira Taguchi et al.

CURRENT MEDICAL RESEARCH AND OPINION (2016)

Review Dentistry, Oral Surgery & Medicine

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

Daniele Rosella et al.

JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY (2016)

Article Dentistry, Oral Surgery & Medicine

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update

Salvatore L. Ruggiero et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)

Article Dentistry, Oral Surgery & Medicine

Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases

SL Ruggiero et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)

Letter Dentistry, Oral Surgery & Medicine

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic

RE Marx

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)